Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

Omeprazole Extended-Release Capsules Supply

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract involves the supply of FDA-regulated Omeprazole Extended-Release Capsules for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The provider is responsible for manufacturing or sourcing 20 mg delayed release capsules that adhere to NSN 6505-01-624-7068, ensuring a minimum remaining shelf life of 21 months. The contract requires the delivery of 17 bottles of medication, with packaging and labeling strictly following ASTM D3951 and Medical Marking Standard No. 1. To be eligible, the supplier must maintain active FDA registration and ensure full compliance with the Buy American Act. The performance of this contract is centered at Fort Bragg, with a response deadline set for November 2, 2026. This procurement falls under NAICS code 325412, focusing on the specialized production and distribution of pharmaceutical preparations.

General Info

Supply 17 bottles of FDA-regulated Omeprazole capsules for DoD delivery by November 2026.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

This scope was carved out of SPE2DP-27-T-0190.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

OMEPRAZOLE EXTENDED-RE

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Supplies FDA-regulated Omeprazole Extended-Release Capsules for prime contractors on DLA Troop Support Medical Supply Chain Pharm FSA projects. Manufactures or sources 20 mg delayed release capsules meeting NSN 6505-01-624-7068, ensuring 21 months remaining shelf life. Packages per ASTM D3951 and labels per Medical Marking Standard No. 1. Requires FDA registration and Buy American Act compliance. Delivers 17 bottles of medication.

Similar Contracts

Same NAICS industry code

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS